Industry ownership intelligence

Health Information Services insider conviction

Executive and director activity assessed across 25 companies for breadth, transaction quality, clustering, freshness, and directional conviction.

Market dashboardHealthcare sectorCompany signalsFiling ledgerData API
28/100

Concentrated distribution

93/100 confidence
Level
Industry
Evidence window
Latest 90 days
Named insiders
145
Latest evidence
10 Sep 2026

Capital positioning read

Concentrated distribution

Priced common-share disposals are concentrated enough to warrant review, but they are not treated as a standalone bearish forecast.

Review exposure and filing context

Evidence in favour

  • 24 distinct acquisition events survive duplicate and security-type controls.
  • Participation spans 145 named insiders rather than one filing source.
  • The latest qualifying evidence is fresh, dated 10 Sep 2026.

Decision risks

  • Qualifying disposal events outnumber acquisitions, although disposals receive a lower directional weight.
Conviction28Concentrated distribution
Confidence93Deep evidence
Controlled events222directional common-share events
Company breadth25represented companies
Acquisition value$9.8Mnormalized amount
Disposal value$56.8Mnormalized amount

Flow regime

Twelve-week filing pressure

Shows the cadence and balance of the full filing tape.

6829 Jun
2806 Jul
3513 Jul
1120 Jul
527 Jul
2403 Aug
6010 Aug
3017 Aug
3824 Aug
8431 Aug
607 Sep
014 Sep
AcquisitionsDisposalsScore 28 · Confidence 93

Relative positioning

Industry peer map

Current score with confidence.

Drug Manufacturers - GeneralBalanced insider tape5594 confidence Pharmaceutical RetailersNo directional read5014 confidence BiotechnologyBalanced insider tape4893 confidence Medical DevicesBalanced insider tape4792 confidence Medical Instruments & SuppliesDistribution bias4192 confidence Diagnostics & ResearchDistribution bias3696 confidence Drug Manufacturers - Specialty & GenericDistribution bias3495 confidence Medical Care FacilitiesConcentrated distribution3287 confidence Healthcare PlansConcentrated distribution3092 confidence Medical DistributionConcentrated distribution3078 confidence Health Information ServicesConcentrated distribution2893 confidence

Directional balance

Controlled event mix

10.8%acquisition
Acquisition events
24
Disposal events
198
Net value
-$47.1M

Evidence quality

What the filings represent

Common equity360
Equity compensation55
Options and derivatives36
Other securities0

Decision makers

Role participation

Director173
Other executive172
CEO and chair36
Finance leadership31
Large holder22
Other or unspecified17

Quality controls

Evidence usability

Normalized values
52%
Priced common share
51%
Named insiders
145
Controlled events
222

Auditable evidence

Latest Health Information Services filings

Showing 1 to 30 of 451.

HCATHealth Catalyst Inc
ALBERT, BENJAMINDirector, CEO
DisposalCommon equity
$59.0KDirectional evidence
TXG10X Genomics Inc
TAICH, ADAMChief Financial Officer
DisposalCommon equity
$2.0MDirectional evidence
TXG10X Genomics Inc
TAICH, ADAMChief Financial Officer
DisposalCommon equity
$897.6KDirectional evidence
VEEVVeeva Systems Inc Class A
HUNG, PRISCILLADirector
DisposalCommon equity
$195.8KDirectional evidence
TXG10X Genomics Inc
TAICH, ADAMChief Financial Officer
DisposalCommon equity
$76.8KDirectional evidence
SOPHSophia Genetics SA
HIBBS, KATHY LDirector
DisposalCommon equity
$50.8KDirectional evidence
TXG10X Genomics Inc
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
$425.3KDirectional evidence
TXG10X Genomics Inc
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
$423.2KDirectional evidence
TXG10X Genomics Inc
STUELPNAGEL, JOHN RDirector
DisposalCommon equity
$386.5KDirectional evidence
TDOCTeladoc Inc
RODRIGUES, FERNANDO M.President of BetterHelp
DisposalCommon equity
$63.9KDirectional evidence
TDOCTeladoc Inc
DIVITA, CHARLES IIIDirector, CHIEF EXECUTIVE OFFICER
DisposalCommon equity
$115.5KDirectional evidence
TDOCTeladoc Inc
VANDERVOORT, ADAM CCHIEF LEGAL OFFICER, SECRETARY
DisposalCommon equity
$47.7KDirectional evidence
TDOCTeladoc Inc
BLISS, KELLYPresident, U.S. Group Health
DisposalCommon equity
$46.4KDirectional evidence
TDOCTeladoc Inc
NUENO, CARLOSPresident, International
DisposalCommon equity
$39.1KDirectional evidence
TDOCTeladoc Inc
RODRIGUES, FERNANDO M.President of BetterHelp
DisposalCommon equity
$34.3KDirectional evidence
TDOCTeladoc Inc
CATAPANO, JOSEPH RONALDChief Accounting Officer
DisposalCommon equity
$1.7KDirectional evidence
CERTCertara Inc
MOHAMMED, FAIZInterim CFO
AcquisitionEquity compensation
Not reportedContext evidence
DOCSDoximity Inc
WAMPLER, KIRA SCHERERDirector
AcquisitionCommon equity
Not reportedContext evidence
DOCSDoximity Inc
WAMPLER, KIRA SCHERERDirector
AcquisitionCommon equity
Not reportedContext evidence
DOCSDoximity Inc
WAMPLER, KIRA SCHERERDirector
DisposalCommon equity
Not reportedContext evidence
DOCSDoximity Inc
WAMPLER, KIRA SCHERERDirector
DisposalOptions and derivatives
Not reportedContext evidence
HCATHealth Catalyst Inc
LARSON-GREEN, JULIEDirector
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
GANDHI, BALAJIChief Financial Officer
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
HOFFMAN, ALLISON CGeneral Counsel & Secretary
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
HUI, YVONNEPrincipal Accounting Officer
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
INDIG, CHAIMDirector, Chief Executive Officer
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
LINETSKY, DAVIDPresident, Network Solutions
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
LINETSKY, DAVIDPresident, Network Solutions
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
ROBERTS, EVANPresident, Provider Solutions
AcquisitionCommon equity
Not reportedContext evidence
PHRPhreesia Inc
VANDUYN, AMY BETHSVP, Human Resources
AcquisitionCommon equity
Not reportedContext evidence

Group-level method

Breadth before headline value

Company breadth

A sector or industry score must be supported across companies. One very large filing cannot manufacture broad conviction.

Economic duplicates

Matching company, date, side, security class, share count, and value records are consolidated for the directional calculation.

Evidence hierarchy

Priced common-share activity determines direction. Compensation and derivative records are mapped separately so ownership mechanics remain visible.

Positioning use

The score identifies where insider alignment merits research or where disposal concentration needs review. Price, trend, valuation, and portfolio risk still decide positioning.

Independent market research for education. This classification is not investment advice, a recommendation, a forecast, or an execution instruction.

Evidence context